Phase 3 trials for three different agents show substantial reductions in kidney function decline and other improvements ...

Upadacitinib, a JAK1 inhibitor, is linked to a lower risk for treatment failure and more steroid-free disease stability than ...

Everyday medical equipment is shedding micro- and nanoplastics into patients, bypassing their bodies’ natural filters and ...

Energy drink use in adolescents may be a marker of sleep debt, and clinicians should treat it as a cue to screen for short ...

An expanding list of treatment options offers new hope for myasthenia gravis, while key questions about personalized therapy ...

Synthesizing medical management strategies with surgical and interventional treatments improves outcomes in patients with ...

Diabetic peripheral neuropathy is among the most common and debilitating complications of type 2 diabetes, but early ...

A pooled phase 3 analysis shows that 15-mg and 20-mg doses of estetrol both reduce the frequency and severity of ...

Moderate or severe silent vertebral fractures are found in 14.6% of asymptomatic adults aged 40-79 years, with a higher ...

As cases rise in that state, CDC shares tips with clinicians on how to recognize and treat the mosquito-borne virus.

Over 5 years of follow-up, depression, but not anxiety, was independently linked to poorer executive function post-stroke; ...

Higher baseline B-cell counts and IL-6 concentrations are associated with an increased risk for cytokine release syndrome ...